Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Keystone

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid ArthritisSafoora Fatima, O Schieir, M F Valois, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2021
ReplySafoora Fatima, O Schieir, E C Keystone, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Consensus statement on the use of rituximab in patients with rheumatoid arthritisJ S Smolen, E C Keystone, P Emery, et al.
ACR Open Rheumatology|November 29, 2019
Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid ArthritisB Kuriya, O Schieir, M F Valois, et al.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.
Annals of the Rheumatic Diseases|December 11, 2008
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD StudyE C Keystone, M C Genovese, L Klareskog, et al.
The Journal of Rheumatology|March 25, 1999
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokineticsI F Anderson, T Helve, P Hannonen, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid ArthritisSafoora Fatima, O Schieir, M F Valois, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2021
ReplySafoora Fatima, O Schieir, E C Keystone, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Consensus statement on the use of rituximab in patients with rheumatoid arthritisJ S Smolen, E C Keystone, P Emery, et al.
ACR Open Rheumatology|November 29, 2019
Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid ArthritisB Kuriya, O Schieir, M F Valois, et al.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.
Annals of the Rheumatic Diseases|December 11, 2008
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD StudyE C Keystone, M C Genovese, L Klareskog, et al.
The Journal of Rheumatology|March 25, 1999
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokineticsI F Anderson, T Helve, P Hannonen, et al.
Pageof 13